After legal battles and lobbying efforts, thousands of people with hepatitis C are gaining earlier access to expensive drugs that can cure this condition. States that limited access to the medications out of concern over sky-high prices have begun to lift those restrictions – many, under the threat of legal action. And commercial insurers such as Anthem Inc. and United HealthCare are doing the same.
Written by Judith Graham on 7/2/16